Example: Heart Attack

Clinical Trials Sponsored by Syntrix Biosystems, Inc

Total 10 results

NCT04683926

Recruiting

A Randomized Study Investigating Oral Desmetramadol Dose Proportionality and Food Effect In Normal Human Subjects

Conditions: Pain
NCT04245397

Recruiting

SX-682 Treatment in Subjects With Myelodysplastic Syndrome Who Had Disease Progression or Are Intolerant to Prior Therapy

Conditions: Myelodysplastic Syndromes
NCT03664921

Completed

Omnitram Safety and Efficacy in the Treatment of Diabetic Neuropathy

Conditions: Diabetic Neuropathies; Neuropathic Pain; Pain, Chronic
NCT03431974

Active, not recruiting

Once-Weekly Oral Aminopterin for the Treatment of Subjects With Moderate-To-Severe Psoriasis

Conditions: Psoriasis
NCT03312777

Completed

Omnitram Pharmacokinetic and Analgesic Study Following CY2D6 Inhibition With Paroxetine In Healthy Volunteers

Conditions: Pain
NCT03161431

Recruiting

SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab

Conditions: Melanoma Stage III; Melanoma Stage IV
NCT02205554

Completed

Omnitram Pharmacokinetic Study In Healthy Volunteers

Conditions: Pain
NCT01724931

Completed

Aminopterin Dose Finding Treatment for Methotrexate-Naïve Rheumatoid Arthritis

Conditions: Rheumatoid Arthritis
NCT00937027

Completed

Aminopterin Pharmacokinetic Study In Moderate to Severe Psoriasis

Conditions: Psoriasis
NCT04477343

Recruiting

A Study to Evaluate the Safety and Tolerability of SX-682 in Combination With Nivolumab as a Maintenance Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Conditions: Pancreatic Ductal Adenocarcinoma; Pancreatic Cancer